{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T06:50:58Z","timestamp":1770965458572,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.clinthera.2007.05.004","type":"journal-article","created":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T11:23:25Z","timestamp":1187090605000},"page":"900-908","source":"Crossref","is-referenced-by-count":27,"title":["Influence of food on the oral bioavailability of rupatadine tablets in healthy volunteers: A single-dose, randomized, open-label, two-way crossover study"],"prefix":"10.1016","volume":"29","author":[{"given":"Anna","family":"Solans","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcel\u00b7l\u00ed","family":"Carb\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I\u00f1aki","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Merlos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2007.05.004_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0022-3565(24)36413-4","article-title":"Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF)","volume":"280","author":"Merlos","year":"1997","journal-title":"J Pharmacol Exp Ther."},{"key":"10.1016\/j.clinthera.2007.05.004_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1081-1206(10)61038-1","article-title":"Effects of rupatadine vs placebo on allergen-induced symptoms in patients exposed to aeroallergens in the Vienna Challenge Chamber","volume":"96","author":"Stuebner","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.clinthera.2007.05.004_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1358\/dot.2003.39.6.799450","article-title":"Rupatadine: A new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis","volume":"39","author":"Izquierdo","year":"2003","journal-title":"Drugs Today."},{"key":"10.1016\/j.clinthera.2007.05.004_bib4","first-page":"245","article-title":"Rupatadine in allergic rhinitis: Pooled analysis of efficacy data","volume":"57","author":"P\u00e9rez","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2007.05.004_bib5","first-page":"22","article-title":"Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: A randomised, double-blind parallel study","volume":"15","author":"Mart\u00ednez-C\u00f3cera","year":"2005","journal-title":"J Investig Allergol Clin Immunol."},{"key":"10.1016\/j.clinthera.2007.05.004_bib6","first-page":"34","article-title":"A randomized, double-blind, parallel-group study, comparing the efficacy and safety of rupatadine (20 and 10 mg), a new PAF and H1 receptorspecific histamine antagonist, to loratadine 10 mg in the treatment of seasonal allergic rhinitis","volume":"14","author":"Saint-Mart\u00ed","year":"2004","journal-title":"J Investig Allergol Clin Immunol."},{"key":"10.1016\/j.clinthera.2007.05.004_bib7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1398-9995.2004.00576.x","article-title":"Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: A comparison study","volume":"59","author":"Guada\u00f1o","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.clinthera.2007.05.004_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000080959","article-title":"Central and peripheral evaluation of rupatadine, a new antihistamine\/platelet-activating factor antagonist at different doses in healthy volunteers","volume":"50","author":"Barbanoj","year":"2004","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.clinthera.2007.05.004_bib9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2165\/00003495-200262100-00005","article-title":"Food-drug interactions","volume":"62","author":"Schmidt","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2007.05.004_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2165\/00003088-199937030-00003","article-title":"Effects of food on clinical pharmacokinetics","volume":"37","author":"Singh","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2007.05.004_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.2165\/00003088-200342130-00001","article-title":"Dietary effects on drug metabolism and transport","volume":"42","author":"Harris","year":"2003","journal-title":"Clin Pharmacokinet."},{"key":"10.1016\/j.clinthera.2007.05.004_bib12","series-title":"Food-effect bioavailability and fed bioequivalence studies","author":"Guidance for Industry","year":"2002"},{"key":"10.1016\/j.clinthera.2007.05.004_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00007691-200002000-00028","article-title":"Influence of dietary components on the gastrointestinal metabolism and transport of drugs","volume":"22","author":"Evans","year":"2000","journal-title":"Ther Drug Monit."},{"key":"10.1016\/j.clinthera.2007.05.004_bib14","series-title":"International Conference on Harmonisation-World Health Organization. Guideline for Good Clinical Practice [EMEA Web site]. ICH Topic E6. Step 5. Note for guidance on Good Clinical Practice (CPMP\/ICH\/135\/95)","author":"European Agency for the Evaluation of Medicinal Products","year":"2002"},{"key":"10.1016\/j.clinthera.2007.05.004_bib15","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/bmj.313.7070.1448a","article-title":"Declaration of Helsinki","volume":"313","author":"World Medical Organization","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2007.05.004_bib16","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1007669411738","article-title":"Bioanalytical method validation: A revisit with a decade of progress","volume":"17","author":"Shah","year":"2000","journal-title":"Pharm Res."},{"key":"10.1016\/j.clinthera.2007.05.004_bib17","series-title":"Bioanalytical method validation","author":"Guidance for Industry","year":"2001"},{"key":"10.1016\/j.clinthera.2007.05.004_bib18","series-title":"Statistical approaches to establishing bioequivalence","author":"Guidance for Industry","year":"2001"},{"issue":"Suppl A","key":"10.1016\/j.clinthera.2007.05.004_bib19","first-page":"189","article-title":"Pharmacokinetic and dose linearity of rupatadine fumarate in healthy volunteers","volume":"19","author":"Izquierdo","year":"1997","journal-title":"Meth Find Exp Clin Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2007.05.004_bib20","first-page":"410","article-title":"Pharmacokinetic and safety profile of rupatadine when co administered with azithromycin. A randomized, cross-over, multiple dose, open study","volume":"159","author":"Solans","year":"2005","journal-title":"Allergy Clin Immunol Int."},{"key":"10.1016\/j.clinthera.2007.05.004_bib21","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1517\/14656566.7.14.1989","article-title":"Rupatadine: Pharmacological profile and its use in the treatment of allergic disorders","volume":"7","author":"Picado","year":"2006","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.clinthera.2007.05.004_bib22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2165\/00003088-198308040-00002","article-title":"Influence of food intake on presystemic clearance of drugs","volume":"8","author":"Melander","year":"1983","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2007.05.004_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00045391-199702000-00005","article-title":"The effect of food on the bioavailability of ebastine","volume":"4","author":"Pentikis","year":"1997","journal-title":"Am J Ther."},{"key":"10.1016\/j.clinthera.2007.05.004_bib24","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/j.1552-4604.1996.tb04759.x","article-title":"Influence of food on the oral bioavailability of loratadine and pseudoephedrine from extendedrelease tablets in healthy volunteers","volume":"36","author":"Nomeir","year":"1996","journal-title":"J Clin Pharmacol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2007.05.004_bib25","first-page":"712","article-title":"Oral bioavailability of desloratadine is unaffected by food","volume":"41","author":"Gupta","year":"2002","journal-title":"Clin Pharmacokinet"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807001336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291807001336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T09:46:35Z","timestamp":1737366395000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291807001336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0149291807001336"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2007.05.004","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}